A newly-released study extends the understanding of how acquired mutations in blood cells act as a new cardiovascular risk factor. Details were reported by the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), Spanish National Center for Cardiovascular Research, the research entity which facilitated the study, published in the journal, Nature Cardiovascular Research.
A team at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with institutes in the USA, has demonstrated that acquired mutations in the gene encoding the protein p53 contribute to the development of atherosclerotic cardiovascular disease.
Genome Guardian Shields Against Heart Disease miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.